5 Most Promising Companies offering hope to patients with Niemann-Pick Type C

Niemann–Pick is a rare autosomal recessive inherited disease that is characterized by excessive accumulation of cholesterol and lipids in cells, leading to apoptosis and neural degeneration. The disease affects numerous body parts such as the brain, nerves, liver, spleen, bone marrow and lungs. Those suffering from the disease suffer from lack of coordination, dystonia; sleep disturbances, difficult in eating and swallowing and frequent bouts of pneumonia.

Therapeutic intervention for Niemann–Pick type C disease must target

Current Clinical Applications of In Vivo Gene Therapy with AAVs - ScienceDirect

Niemann–Pick disease type C Therapeutics Market - NPC Therapeutics Market

Parents of kids with Niemann Pick C advocate for adrabetadex

Update: Twins who were face of controversial rare disease treatment have died, Science

Endpoint Considerations to FacilitateDrug Development for Niemann-Pick Type C (NPC)

Drug Repurposing for Rare Diseases: Trends in Pharmacological Sciences

Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier: Molecular Therapy

5 Most Promising Companies offering hope to patients with Niemann-Pick Type C

First Life Saved with AI-Discovered Repurposed Medicine for Castleman Disease with Significant Potential Applications to Treat Other Illnesses

And Life Goes OnAn Angel and a Rainbow: October 2017

Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption - ScienceDirect

And Life Goes OnAn Angel and a Rainbow: October 2017